Mirtazapine in the treatment of panic disorder.
Carli
Vladimir
V
Sarchiapone
Marco
M
Camardese
Giovanni
G
Romano
Luisa
L
DeRisio
Sergio
S
D000293:Adolescent; D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006179:Gyrus Cinguli / Q000098:blood supply / Q000000981:diagnostic imaging; D006624:Hippocampus / Q000098:blood supply / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D008803:Mianserin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D000078785:Mirtazapine; D016584:Panic Disorder / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D010296:Parietal Lobe / Q000098:blood supply / Q000000981:diagnostic imaging; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D012039:Regional Blood Flow / Q000187:drug effects; D019690:Technetium Tc 99m Exametazime; D015899:Tomography, Emission-Computed, Single-Photon / Q000706:statistics & numerical data; D016896:Treatment Outcome
D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D019690:Technetium Tc 99m Exametazime; D000078785:Mirtazapine